• Magnetic Nano-Antibody Enables In Vivo CAR-T Mimicry for Tum

  2026-05-19

  This study introduces a magnetic bispecific nano-antibody (M-BiNanoAb) platform that enables the in vivo generation and magnetic navigation of CAR-T-mimicking effector cells. By directly reprogramming circulating T cells and enhancing their tumor infiltration, this strategy addresses longstanding barriers in solid tumor immunotherapy with promising translational potential.

• Optimizing Assays with EZ Cap™ Firefly Luciferase mRNA (R101

  2026-05-18

  This article explores real-world challenges in cell-based assays and demonstrates how EZ Cap™ Firefly Luciferase mRNA (SKU R1018) delivers reliable, quantitative solutions. By integrating workflow scenarios, comparative vendor analysis, and evidence-backed protocol advice, scientists can advance assay reproducibility and data integrity using this advanced bioluminescent reporter mRNA.

• Deferasirox Fe3+ Chelate: Workflow Optimization in Iron Over

  2026-05-18

  Deferasirox Fe3+ chelate stands apart as a DMSO-soluble, high-purity standard for iron overload and beta-thalassemia research. Discover best practices, troubleshooting tips, and data-driven protocol enhancements that maximize reproducibility and mechanistic insight in hematology workflows.

• Eicosapentaenoic Acid: Protocol Innovations for Cardiovascul

  2026-05-17

  Eicosapentaenoic Acid (EPA) empowers cardiovascular and immunological research with high-impact, reproducible workflows and precise lipid-lowering and anti-inflammatory actions. This guide details advanced assay set-ups, troubleshooting strategies, and key innovations—anchored in both new mechanistic data and APExBIO’s quality standards—to accelerate bench-to-publication success.

• Nelfinavir Mesylate: HIV-1 Protease Inhibitor and Ferroptosi

  2026-05-16

  Nelfinavir Mesylate is a potent, orally bioavailable HIV-1 protease inhibitor with nanomolar efficacy in vitro. Recent evidence also implicates it in modulating ferroptosis sensitivity via DDI2 inhibition. This dual functionality supports its use in HIV infection research and emerging cell death studies.

• Paclitaxel (Taxol): Quantitative Assay Design for Cell Cycle

  2026-05-15

  Discover how Paclitaxel (Taxol) enables quantitative, mechanism-driven assay design in cancer research. This article uniquely explores in vitro evaluation metrics and practical decisions for cell cycle arrest studies.

• Ferritin Hybrid Protein Vaccine: M2e and SARS-CoV-2 STE Inte

  2026-05-15

  This study introduces a ferritin-based hybrid protein vaccine, integrating the influenza A M2e antigen and tandem epitopes from the SARS-CoV-2 S-protein via E. coli expression. The resulting nanoparticles demonstrate enhanced immunogenicity and cross-protective potential, offering a versatile platform for combination viral vaccines.

• Veratridine as a Voltage-Gated Sodium Channel Opener in Rese

  2026-05-14

  Veratridine, a potent voltage-gated sodium channel opener, is pivotal in dissecting sodium channel function, modeling disease phenotypes, and screening for channel modulators. This guide delivers actionable workflows and troubleshooting strategies, empowering researchers to harness Veratridine’s mechanistic precision across neuroscience and cardiac research applications.

• Sulfamonomethoxine in Veterinary & Aquatic Workflows: Applie

  2026-05-14

  Sulfamonomethoxine (SMM) is a cornerstone veterinary antibiotic and aquaculture feed additive, uniquely positioned for both efficacy studies and environmental safety benchmarks. This guide translates leading research and APExBIO’s formulation advantages into actionable protocols, troubleshooting strategies, and data-backed optimizations for reliable lab results.

• Sulfaphenazole: Selective CYP2C9 Inhibitor for Precision Res

  2026-05-13

  Sulfaphenazole is a potent CYP2C9 inhibitor with validated antibacterial and vascular-protective effects. It enables precise modulation of drug metabolism and has low cytotoxicity, supporting robust applications in both enzymology and anti-tuberculosis studies.

• A-769662: Rethinking AMPK Activation for Translational Scien

  2026-05-13

  This thought-leadership article reframes the utility of A-769662, a potent AMPK activator, in light of recent paradigm-shifting insights into AMPK’s dual role in energy stress and autophagy. By synthesizing mechanistic evidence, translational opportunities, and protocol guidance, it provides strategic direction for bench scientists and translational researchers tackling metabolic disease and cellular homeostasis.

• Nystatin (Fungicidin): Optimizing Antifungal Workflows & Ins

  2026-05-12

  Nystatin (Fungicidin) is a cornerstone antifungal for in vitro and translational research, offering robust inhibition of Candida species and unique utility in dissecting endocytic pathways. This article delivers practical workflows, troubleshooting strategies, and pivotal insights from the latest mechanistic studies, empowering researchers to maximize experimental reproducibility and innovation.

• GSK J4 HCl: Precision JMJD3 Inhibition for Epigenetic Workfl

  2026-05-12

  Leverage GSK J4 HCl’s superior cell permeability and selectivity for robust JMJD3 inhibition in advanced epigenetic and inflammation studies. This guide unpacks workflow optimization, quantitative benchmarks, and troubleshooting strategies that empower researchers to translate chromatin regulation insights into actionable results.

• Artesunate in Cancer Biology: Beyond Ferroptosis to Precisio

  2026-05-11

  Explore how Artesunate, a potent artemisinin derivative, enables next-generation assay design and decision-making in cancer biology. This article offers a unique, in-depth analysis integrating mechanistic insights and best-practice evaluation metrics for high-impact research.

• KU-60019: Selective ATM Kinase Inhibitor for Glioma Research

  2026-05-11

  KU-60019 is a potent ATM kinase inhibitor that selectively sensitizes glioma cells to radiation by disrupting DNA damage response pathways. It significantly inhibits cell migration and invasion in vitro, and enhances tumor suppression in vivo when combined with radiation. This article details its mechanisms, benchmarks, and optimal research workflows.

455 records 18/31 page Previous Next First page 上5页 1617181920 下5页 Last page